questionsmedicales.fr
Maladies urogénitales
Maladies génitales
Infections à Chlamydia
Infections à Chlamydia : Questions médicales fréquentes
Diagnostic
5
Chlamydia
Diagnostic médical
Chlamydia
Tests de laboratoire
Précision des tests
Chlamydia
Symptômes
5
Temps d'apparition
Chlamydia
Traitements
5
Partenaires sexuels
Chlamydia
Durée du traitement
Chlamydia
Effets secondaires
Antibiotiques
Complications
5
Douleurs chroniques
Chlamydia
Facteurs de risque
5
Facteurs de risque
Chlamydia
Immunodépression
Chlamydia
Accès aux soins
Chlamydia
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Infections à Chlamydia : Questions médicales les plus fréquentes",
"headline": "Infections à Chlamydia : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Infections à Chlamydia : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-18",
"dateModified": "2026-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Infections à Chlamydia"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies génitales",
"url": "https://questionsmedicales.fr/mesh/D000091662",
"about": {
"@type": "MedicalCondition",
"name": "Maladies génitales",
"code": {
"@type": "MedicalCode",
"code": "D000091662",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lymphogranulomatose vénérienne",
"alternateName": "Lymphogranuloma Venereum",
"url": "https://questionsmedicales.fr/mesh/D008219",
"about": {
"@type": "MedicalCondition",
"name": "Lymphogranulomatose vénérienne",
"code": {
"@type": "MedicalCode",
"code": "D008219",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.100.937.281.301.490"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Infections à Chlamydia",
"alternateName": "Chlamydia Infections",
"code": {
"@type": "MedicalCode",
"code": "D002690",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "William M Geisler",
"url": "https://questionsmedicales.fr/author/William%20M%20Geisler",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Kanupriya Gupta",
"url": "https://questionsmedicales.fr/author/Kanupriya%20Gupta",
"affiliation": {
"@type": "Organization",
"name": "From the Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL."
}
},
{
"@type": "Person",
"name": "Barbara Van Der Pol",
"url": "https://questionsmedicales.fr/author/Barbara%20Van%20Der%20Pol",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Stephanie R Lundy",
"url": "https://questionsmedicales.fr/author/Stephanie%20R%20Lundy",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA, 30310, USA."
}
},
{
"@type": "Person",
"name": "Francis O Eko",
"url": "https://questionsmedicales.fr/author/Francis%20O%20Eko",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA, 30310, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Interferon-ε as potential inhibitor of Chlamydia trachomatis infection.",
"datePublished": "2023-10-27",
"url": "https://questionsmedicales.fr/article/37890679",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.micpath.2023.106427"
}
},
{
"@type": "ScholarlyArticle",
"name": "Chlamydia pneumonia infection and risk of multiple sclerosis: A meta-analysis.",
"datePublished": "2023-06-29",
"url": "https://questionsmedicales.fr/article/37442074",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.msard.2023.104862"
}
},
{
"@type": "ScholarlyArticle",
"name": "Infection of human organoids supports an intestinal niche for Chlamydia trachomatis.",
"datePublished": "2024-08-22",
"url": "https://questionsmedicales.fr/article/39172739",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.ppat.1012144"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Guidelines for the Diagnosis and Treatment of Uncomplicated (Non-Lymphogranuloma Venereum) Chlamydia trachomatis Infection in Portugal].",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38848698",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.20344/amp.21442"
}
},
{
"@type": "ScholarlyArticle",
"name": "Seminal plasma inhibits Chlamydia trachomatis infection in vitro, and may have consequences on mucosal immunity.",
"datePublished": "2024-09-09",
"url": "https://questionsmedicales.fr/article/39251689",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-71499-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies urogénitales",
"item": "https://questionsmedicales.fr/mesh/D000091642"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies génitales",
"item": "https://questionsmedicales.fr/mesh/D000091662"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections à Chlamydia",
"item": "https://questionsmedicales.fr/mesh/D002690"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Infections à Chlamydia - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Infections à Chlamydia",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Infections à Chlamydia",
"description": "Comment diagnostique-t-on une infection à Chlamydia ?\nQuels tests sont utilisés pour détecter Chlamydia ?\nLes tests de dépistage sont-ils recommandés ?\nPeut-on diagnostiquer Chlamydia par des symptômes ?\nQuelle est la précision des tests de Chlamydia ?",
"url": "https://questionsmedicales.fr/mesh/D002690#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Infections à Chlamydia",
"description": "Quels sont les symptômes courants d'une infection à Chlamydia ?\nLes hommes ressentent-ils des symptômes ?\nLes infections à Chlamydia peuvent-elles être asymptomatiques ?\nQuels symptômes peuvent indiquer une complication ?\nLes symptômes apparaissent-ils rapidement ?",
"url": "https://questionsmedicales.fr/mesh/D002690#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Infections à Chlamydia",
"description": "Comment prévenir les infections à Chlamydia ?\nLe dépistage régulier est-il important ?\nLes vaccins existent-ils contre Chlamydia ?\nLes relations monogames réduisent-elles le risque ?\nLes jeunes adultes doivent-ils être particulièrement vigilants ?",
"url": "https://questionsmedicales.fr/mesh/D002690#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Infections à Chlamydia",
"description": "Quel est le traitement standard pour Chlamydia ?\nLes partenaires doivent-ils être traités ?\nCombien de temps dure le traitement ?\nLes infections à Chlamydia peuvent-elles récidiver ?\nY a-t-il des effets secondaires aux antibiotiques ?",
"url": "https://questionsmedicales.fr/mesh/D002690#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Infections à Chlamydia",
"description": "Quelles sont les complications possibles d'une infection à Chlamydia ?\nComment Chlamydia affecte-t-elle la fertilité ?\nLes infections à Chlamydia peuvent-elles causer des douleurs chroniques ?\nLes femmes enceintes sont-elles à risque de complications ?\nChlamydia peut-elle augmenter le risque de VIH ?",
"url": "https://questionsmedicales.fr/mesh/D002690#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Infections à Chlamydia",
"description": "Quels sont les principaux facteurs de risque pour Chlamydia ?\nLes antécédents d'infections sexuellement transmissibles augmentent-ils le risque ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nLe manque d'accès aux soins de santé influence-t-il le risque ?\nLes jeunes femmes sont-elles particulièrement vulnérables ?",
"url": "https://questionsmedicales.fr/mesh/D002690#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection à Chlamydia ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests urinaires ou des prélèvements cervicaux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter Chlamydia ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les cultures cellulaires sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils recommandés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage est recommandé pour les personnes à risque, notamment les jeunes adultes."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer Chlamydia par des symptômes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent indiquer une infection, mais beaucoup de cas sont asymptomatiques."
}
},
{
"@type": "Question",
"name": "Quelle est la précision des tests de Chlamydia ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR sont très sensibles et spécifiques, offrant une bonne précision."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection à Chlamydia ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs pelviennes, des pertes vaginales ou urinaires anormales."
}
},
{
"@type": "Question",
"name": "Les hommes ressentent-ils des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes peuvent avoir des douleurs lors de la miction ou des écoulements du pénis."
}
},
{
"@type": "Question",
"name": "Les infections à Chlamydia peuvent-elles être asymptomatiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses personnes infectées ne présentent aucun symptôme."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une complication ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales sévères ou de la fièvre peuvent signaler des complications."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître plusieurs semaines après l'infection."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections à Chlamydia ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation de préservatifs et le dépistage régulier sont des méthodes efficaces."
}
},
{
"@type": "Question",
"name": "Le dépistage régulier est-il important ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage régulier aide à détecter les infections asymptomatiques."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils contre Chlamydia ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin efficace contre Chlamydia."
}
},
{
"@type": "Question",
"name": "Les relations monogames réduisent-elles le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des relations monogames avec un partenaire testé réduit le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les jeunes adultes doivent-ils être particulièrement vigilants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes sont à risque élevé et devraient se faire dépister régulièrement."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour Chlamydia ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard est une antibiothérapie, souvent avec de l'azithromycine ou de la doxycycline."
}
},
{
"@type": "Question",
"name": "Les partenaires doivent-ils être traités ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est essentiel que tous les partenaires sexuels soient traités pour éviter la réinfection."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dure généralement 7 jours, mais peut varier selon le médicament."
}
},
{
"@type": "Question",
"name": "Les infections à Chlamydia peuvent-elles récidiver ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections peuvent récidiver si les partenaires ne sont pas traités."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux antibiotiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des diarrhées ou des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection à Chlamydia ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la maladie inflammatoire pelvienne et l'infertilité."
}
},
{
"@type": "Question",
"name": "Comment Chlamydia affecte-t-elle la fertilité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Chlamydia peut provoquer des cicatrices dans les trompes de Fallope, entraînant l'infertilité."
}
},
{
"@type": "Question",
"name": "Les infections à Chlamydia peuvent-elles causer des douleurs chroniques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent développer des douleurs pelviennes chroniques après une infection."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections à Chlamydia peuvent entraîner des complications pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Chlamydia peut-elle augmenter le risque de VIH ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une infection à Chlamydia peut augmenter le risque de transmission du VIH."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour Chlamydia ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent un nombre élevé de partenaires sexuels et un âge jeune."
}
},
{
"@type": "Question",
"name": "Les antécédents d'infections sexuellement transmissibles augmentent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents d'IST augmente le risque d'infection à Chlamydia."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées peuvent être plus susceptibles aux infections à Chlamydia."
}
},
{
"@type": "Question",
"name": "Le manque d'accès aux soins de santé influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un accès limité aux soins de santé peut augmenter le risque d'infections non traitées."
}
},
{
"@type": "Question",
"name": "Les jeunes femmes sont-elles particulièrement vulnérables ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes femmes sont à risque accru en raison de facteurs biologiques et sociaux."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 08/04/2026
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
4 publications dans cette catégorie
Affiliations :
From the Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Publications dans "Infections à Chlamydia" :
3 publications dans cette catégorie
Publications dans "Infections à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA, 30310, USA.
Publications dans "Infections à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA, 30310, USA.
Publications dans "Infections à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA, 30310, USA. yomosun@msm.edu.
Molecular Pathogenesis Laboratory, Centers for Disease Control & Prevention (CDC), Atlanta, GA, 30333, USA. yomosun@msm.edu.
Publications dans "Infections à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Department of Microbial Pathogenesis, University of Maryland School of Medicine, Baltimore, MD, USA.
Publications dans "Infections à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Publications dans "Infections à Chlamydia" :
3 publications dans cette catégorie
Affiliations :
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Publications dans "Infections à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Publications dans "Infections à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Publications dans "Infections à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia. k2.beagley@qut.edu.au.
Publications dans "Infections à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Department of Bacteriology, Host-Pathogen Interaction and Diagnostics Development, Wageningen Bioveterinary Research, Lelystad, The Netherlands. marloes.heijne@wur.nl.
Publications dans "Infections à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina.
Publications dans "Infections à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina.
Publications dans "Infections à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Molecular Pathogenesis Laboratory, Centers for Disease Control & Prevention (CDC), Atlanta, GA, 30333, USA.
Publications dans "Infections à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology, Morehouse School of Medicine, Atlanta, GA, 30310, USA.
Publications dans "Infections à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Molecular Pathogenesis Laboratory, Centers for Disease Control & Prevention (CDC), Atlanta, GA, 30333, USA.
Publications dans "Infections à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology and Athens Veterinary Diagnostic Laboratory, University of Georgia, College of Veterinary Medicine, Athens, GA, 30602, USA.
Publications dans "Infections à Chlamydia" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology, Morehouse School of Medicine, Atlanta, GA, 30310, USA.
Publications dans "Infections à Chlamydia" :
Chlamydia trachomatis, the main cause of bacterial sexually transmitted diseases, is responsible for severe reproductive sequelae. Amongst all the cytokines involved in host immunity towards this path...
The role of infectious agents, including Chlamydia pneumoniae (Cpn), in the development of multiple sclerosis (MS), is still a matter of major contention....
This meta-analysis study aimed to assess the actual involvement of Cpn in MS development....
We undertook a search of international scientific databases to identify eligible studies. We used a random-effects meta-analysis model (REM) to generate the pooled odds ratio (OR) and 95% confidence i...
We identified 37 studies comprising 51 datasets that satisfied the inclusion criteria. Considering diagnostic methods for Cpn, 26 and 25 datasets used PCR- and serological-based methods, respectively....
Our findings verify the significant positive relationship between Cpn infection and MS. We advocate prospective cohort studies with lifelong follow-ups and also experimental studies to better understa...
Several reports suggest that intestinal tissue may be a natural niche for Chlamydia trachomatis infection and a reservoir for persistent infections in the human body. Due to the human specificity of t...
Chlamydia trachomatis infection is the most prevalent sexually transmitted bacterial infection in the world. Being associated with a large number of asymptomatic carriers, the diagnosis is frequently ...
Seminal plasma (SP) is the main vector of C. trachomatis (CT) during heterosexual transmission from male to female. It has immunomodulatory properties and impacts the susceptibility to HIV-1 infection...
Availability of laboratory confirmation of sexually transmitted infections is increasing in low- and middle-income countries, but costs continue to limit their access. Chlamydia trachomatis (CT) is a ...
Women with fertility intentions were included in this cross-sectional analysis. Logistic regression was used to estimate odds ratios for the association between demographic, medical, reproductive, and...
The prevalence of CT was 7.4% (51 of 691). A risk score for predicting CT infection, with scores 0 to 6, was derived from participants' age, alcohol use, and presence of bacterial vaginosis. The predi...
In similar populations of women planning pregnancies, this type of risk score could be useful for prioritizing women for laboratory testing and would capture most women with CT infections while perfor...
Tubal factor infertility (TFI) is common in sub-Saharan Africa and often secondary to pelvic inflammatory disease (PID). Anaerobes associated with bacterial vaginosis (BV) are also found in PIDs widel...
To determine the prevalence of BV and C. trachomatis and to investigate the association between BV, C. trachomatis and TFI....
We included 137 patients treated for infertility between January 2020 and November 2021. Cases were defined as women with infertility aged 18-45 years presenting with TFI (n = 52), and controls as inf...
The prevalence of BV and C. trachomatis was 42.3% (58/137) and 23.4% (32/137), respectively. BV (61.5% vs 30.6%, p<0.001) and C. trachomatis (48.1 vs 8.2%, p<0.001) were more frequent in cases of TFI....
BV and C. trachomatis infection are strongly associated with TFI in Bukavu. Prevention and screening should be implemented to reduce the risk of TFI....
There is increasing debate regarding the harms and benefits of frequent asymptomatic screening for Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men (MSM). One concern is th...
Prior to COVID-19 pandemic, a yearly upward trajectory in the number of chlamydia infection cases was observed in South Korea. However, in response to the COVID-19 pandemic, Korea implemented several ...
Using the monthly number of reported chlamydia infection data between 2017 and 2022, we compared the trends in the reported numbers, and the incidence rates (IR) of chlamydia infection stratified by d...
We observed an irregular downward trajectory in the number of chlamydia infection in the during-pandemic period. A 30% decrease in the total number of chlamydia infection was estimated in the during-p...
We identified decrease in the number of chlamydia infection during COVID-19 pandemic which is likely due to underdiagnosis and underreporting for the infection. Therefore, strengthening surveillance f...
Chlamydia genital infections continue to be a serious health concern globally. Previous studies have reported that Chlamydia trachomatis infection alters the vaginal microbiota of infected women. This...
This was a cross-sectional study among 385 pregnant women, recruited from the King Edward VIII Hospital in Durban, South Africa. C. trachomatis was detected using the Applied Biosystems™ TaqMan...
The prevalence of C. trachomatis infection was 12.2% (47/385). The genus Gardnerella (32.14% vs. 24.02%) and species in the genus Gardnerella (31.97% vs. 24.03%) were more abundant in the C. trachomat...
The organisms and taxa that significantly contributed to separating the vaginal microbiota of C. trachomatis-infected women from the uninfected women in this study cohort have not been previously obse...